Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Milena Cappello

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Dermatologic Therapy|May 25, 2019
Efficacy and safety of vismodegib in patients with basal cell carcinoma: An Italian Center experienceMassimiliano Scalvenzi, Alessia Villani, Claudia Costa, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|October 24, 2018
Clotrimazole-related allergic contact dermatitisMaddalena Napolitano, Milena Cappello, Bianca Festa, et al.
International Journal of Dermatology|August 23, 2018
Difficult to diagnose small cutaneous melanoma metastases mimicking angiomas: utility of dermoscopyCaterina Mazzella, Claudia Costa, Milena Cappello, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|May 17, 2017
Skin diseases and tattoos: a five-year experienceMaddalena Napolitano, Matteo Megna, Milena Cappello, et al.
The Australasian Journal of Dermatology|October 11, 2020
Assessment of the adverse events related to hedgehog pathway inhibitor therapy for basal cell carcinoma: A single-centre retrospective studyAlessia Villani, Gabriella Fabbrocini, Claudia Costa, et al.
Italian Journal of Dermatology and Venereology|May 21, 2019
Effective and tolerable treatment of advanced basal cell carcinoma with vismodegib despite other malignanciesAlessia Villani, Claudia Costa, Milena Cappello, et al.
Dermatology and Therapy|June 6, 2019
Real-Life Effectiveness of Vismodegib in Patients with Metastatic and Advanced Basal Cell Carcinoma: Characterization of Adverse Events and Assessment of Health-Related Quality of Life using the Dermatology Life Quality Index (DLQI) TestAlessia Villani, Gabriella Fabbrocini, Milena Cappello, et al.
Journal of the American Academy of Dermatology|May 8, 2020
Reply to: "Comparison of daily dosing vs. Monday through Friday dosing of vismodegib for locally advanced basal cell carcinoma (laBCC) and basal cell nevus syndrome: A retrospective case series"Alessia Villani, Claudia Costa, Gabriella Fabbrocini, et al.
Dermatology and Therapy|April 3, 2020
Low-Dose Vismodegib as Maintenance Therapy After Locally Advanced Basal Cell Carcinoma Complete Remission: High Efficacy with Minimal ToxicityMassimiliano Scalvenzi, Milena Cappello, Claudia Costa, et al.
Skin Appendage Disorders|December 14, 2020
Vismodegib-Induced Alopecia: Trichoscopic and Confocal Microscopy EvaluationMariateresa Cantelli, Milena Cappello, Maria Vastarella, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Dermatologic Therapy|May 25, 2019
Efficacy and safety of vismodegib in patients with basal cell carcinoma: An Italian Center experienceMassimiliano Scalvenzi, Alessia Villani, Claudia Costa, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|October 24, 2018
Clotrimazole-related allergic contact dermatitisMaddalena Napolitano, Milena Cappello, Bianca Festa, et al.
International Journal of Dermatology|August 23, 2018
Difficult to diagnose small cutaneous melanoma metastases mimicking angiomas: utility of dermoscopyCaterina Mazzella, Claudia Costa, Milena Cappello, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|May 17, 2017
Skin diseases and tattoos: a five-year experienceMaddalena Napolitano, Matteo Megna, Milena Cappello, et al.
The Australasian Journal of Dermatology|October 11, 2020
Assessment of the adverse events related to hedgehog pathway inhibitor therapy for basal cell carcinoma: A single-centre retrospective studyAlessia Villani, Gabriella Fabbrocini, Claudia Costa, et al.
Italian Journal of Dermatology and Venereology|May 21, 2019
Effective and tolerable treatment of advanced basal cell carcinoma with vismodegib despite other malignanciesAlessia Villani, Claudia Costa, Milena Cappello, et al.
Dermatology and Therapy|June 6, 2019
Real-Life Effectiveness of Vismodegib in Patients with Metastatic and Advanced Basal Cell Carcinoma: Characterization of Adverse Events and Assessment of Health-Related Quality of Life using the Dermatology Life Quality Index (DLQI) TestAlessia Villani, Gabriella Fabbrocini, Milena Cappello, et al.
Journal of the American Academy of Dermatology|May 8, 2020
Reply to: "Comparison of daily dosing vs. Monday through Friday dosing of vismodegib for locally advanced basal cell carcinoma (laBCC) and basal cell nevus syndrome: A retrospective case series"Alessia Villani, Claudia Costa, Gabriella Fabbrocini, et al.
Dermatology and Therapy|April 3, 2020
Low-Dose Vismodegib as Maintenance Therapy After Locally Advanced Basal Cell Carcinoma Complete Remission: High Efficacy with Minimal ToxicityMassimiliano Scalvenzi, Milena Cappello, Claudia Costa, et al.
Skin Appendage Disorders|December 14, 2020
Vismodegib-Induced Alopecia: Trichoscopic and Confocal Microscopy EvaluationMariateresa Cantelli, Milena Cappello, Maria Vastarella, et al.
Pageof 2